IVUS use during left main PCI increased significantly from 16% in 2015-2019 to 38% in 2020-2022 (p<0.001), but remained underutilized overall at 22% across the study period.
Observational (n=863)
Sí
IVUS use during left main PCI has progressively increased over time, reflecting the uptake of clinical guidelines, but it remains underutilized.
Tasa de eventos absoluta: 38% vs 16%
valor p: p=<0.001
Background: Intravascular ultrasound (IVUS) is an important endovascular imaging tool to guide percutaneous coronary interventions (PCI).Adoption in contemporary PCI practice has been lower than expected despite endorsement in clinical practice guidelines with upgrade of IVUS-guided PCI for left main (LM) disease to 2a recommendation in the 2021 ACC/AHA/SCAI guidelines.We assessed the evolution of IVUS use in LM PCI in a multicenter cardiac cath lab registry over time in relation to changes in clinical practice guidelines.Methods: LM PCI cases (n=863) were identified in the IU Health multicenter cath lab registry which includes 7 participating hospitals between 2015-2022.Procedural details were recorded prospectively for the registry and IVUS use was analyzed according to the year performed.Results: Patients who underwent left main PCI were elderly and had many comorbidities.The average age was 69 years, with 66% male (n=568) and 34% being female (n=295).IVUS was used in 195 of cases (22%).The use of IVUS increased progressively over time (see Figure 1) with the most frequent use of IVUS in the last year of the registry (2022) when it was used in 41.9% of cases (n=39).IVUS use was higher in 2020-2022 compared to 2015-2019 (38% vs 16%; p<0.001).Conclusions: Overall, IVUS use during LM PCI increased over time reflecting uptake of clinical trials evidence and clinical guideline recommendation in contemporary practice but remained underutilized.
Komanapalli et al. (miércoles) realizaron un estudio observacional en enfermedad de la arteria coronaria principal izquierda (n=863). Se evaluó el uso de ultrasonido intravascular (IVUS) frente a la comparación temporal (2015-2019 vs 2020-2022) en el uso de IVUS durante la PCI de la arteria coronaria principal izquierda a lo largo del tiempo (p=<0.001). El uso de IVUS durante la PCI de la arteria coronaria principal izquierda aumentó significativamente del 16% en 2015-2019 al 38% en 2020-2022 (p<0.001), pero permaneció infrautilizado en general con un 22% durante el período del estudio.